Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis

Experimental Eye Research

Volumn 128, Issue , 2014, Pages 73-82

  Sai Varsha, M K N ^a   Raman, Thiagarajan ^a   Manikandan, Ramar ^b  

^a SASTRA UNIVERSITY   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

Calcium; Calcium ATPase; Diabetic cataract; Natural product; Oxidative stress; Vitamin K1

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADVANCED GLYCATION END PRODUCT; CALCIUM; FARNOQUINONE; GLUCOSE; PHYTOMENADIONE; SORBITOL; STREPTOZOCIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); GLUCOSE BLOOD LEVEL; GLUTATHIONE; HYDROXYL RADICAL; SUPEROXIDE; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CALCIUM HOMEOSTASIS; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CATARACT; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; LENS; LOW DRUG DOSE; MALE; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HOMEOSTASIS; HYDROXYL RADICAL; HYPERGLYCEMIA; LENS, CRYSTALLINE; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SORBITOL; SUPEROXIDES; VITAMIN K 1; VITAMINS;

EID: 84907880606     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.09.007     Document Type: Article

References (60)

1. Babizhayev M.A., Costa E.B. Lipid peroxide and reactive oxygen species generating systems of the crystallin lens. Biochim. Biophys. Acta 1994, 1225:326-337.
2. Benedetti A., Fulceri R., Comporti M. Inhibition of calcium sequestration activity of liver microsomes by 4-hydroxyalkenals originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 1984, 793:489-493.
3. Bergad P.L., Rathbun W.B. Inhibition of Na-K-ATPase by sodium selenite and reversal by glutathione. Curr. Eye Res. 1986, 5:919-923.
4. Bhuyan K.C., Bhuyan D.K., Santos O., Podos S.M. Antioxidant and anticataractogenic effects of topical captopril in diquat-induced cataract in rabbits. Free Radic. Biol. Med. 1992, 12:251-261.
5. Brito P.N., Rosas V.M., Coentrao L.M., Carneiro A.V., Rocha-Sousa A., Brandao E., Falco-Reis F., Falcao M.A. Evaluation of visual acuity, macular status, and subfoveal choroidal thickness changes after cataract surgery in eyes with diabetic retinopathy. Retina 2014, 10.1097/IAE.0000000000000298.
6. Cooper K.E., Tang J.M., Rae J.L., Eisenberg R.S. Acation channel in frog lens epithelia responsive to pressure and calcium. J.Membr. Biol. 1986, 93:256-269.
7. Dalmeijer G.W., van der Schouw Y.T., Magdeleyns E.J. Matrix gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care 2013, 36:3766-3771.
8. David L.L., Shearer T.R. Calcium activated proteolysis in the lens nucleus during selenite cataractogenesis. Invest. Ophthalmol. Vis. Sci. 1984, 25:1275-1283.
9. Duncan G., Williams M.R., Riach R.A. Calcium, cell signaling and cataract. Prog. Retin Eye Res. 1994, 12:623-651.
10. Gutierzz R.M.P., Cotera L.B.F., Gonzalez A.M.N. Evaluation of the antioxidant and anti-glycation effects of the hexane extract from Piper auritum leaves invitro and beneficial activity on oxidative stress and advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Molecules 2012, 17:11897-11919.
11. Halder N., Joshi S., Gupta K.S. Lens aldose reductase inhibiting potential of some indigenous plants. J.Ethnopharmacol. 2003, 86:113-116.
12. Hamada Y., Araki N., Koh N., Nakamura J., Horiuchi S., Hotta N. Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem. Biophys. Res. Commun. 1996, 228:539-543.
13. Haroon Y., Bacon D.S., Sadowski J.A. Liquid-chromatographic determination of vitamin K1 in plasma, with fluorometric detection. Clin. Chem. 1986, 32:1925-1930.
14. Hightower K.R., Kinsey V.E. Transport and bioelectric properties of post-mortem lenses. Exp. Eye Res. 1980, 30:9-28.
15. Horiuchi T., Kazama H., Araki A. Impaired gamma carboxylation of osteocalcin in elderly women with type II diabetes mellitus: relationship between increase in undercarboxylated osteocalcin levels and low bone mineral density. J.Bone Min. Metab. 2004, 22:236-240.
16. Huber M.J.E., Smith S.A., Smith S.E. Mydriatic drugs for diabetic patients. Br. J. Ophthalmol. 1985, 69:425-427.
17. Iwamoto J., Sato Y., Takeda T., Matsumoto H. Bone quality and vitamin K2 in type 2 diabetes: review of preclinical and clinical studies. Nutr. Rev. 2011, 69:162-167.
18. Iwamoto J., Seki Sato Y., Matsumoto H., Takeda T., Yeh J.K. Vitamin K2 prevents hyperglycemia and cancerous osteopenia in rats with streptozotocin-induced type 1 diabetes. Calcif. Tissue Int. 2011, 88:162-168.
19. Iwasaki Y., Yamato H., Murayama H., Takhashi T., Ezwa I., Kurokawa K., Fukgawa M. Menatetrenone prevents osteoblast dysfunctionbin unilateral sciatic neurectomized rats. Jpn. J. Pharmacol. 2002, 90:88-93.
20. Juanola-Falgarona M., Salas-Salvado J., Monica B. Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc. Diabetol. 2013, 8:12-17.
21. Kagan V.E., Arlchipenko Y.V., Meerson F.Z., Kozlov Y.P. Modification of an enzymatic system of calcium transport in sarcoplasmic reticulum membranes during lipid peroxidation. Biokhimiia 1983, 48:1141-1148.
22. Kinoshita J.H. Mechanisms initiating cataract formation. Invest. Ophthalmol. Vis. Sci. 1974, 13:713-724.
23. Lee Y.W.A., Chung S.M.S. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999, 13:23-30.
24. Li J.H., Huang X.R., Zhu H., Oldfield M., Cooper M., Truong L.D., Johnson R.J., Lan H.Y. Advanced glycation end products activate Smad signaling via TGFβ-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J. 2004, 18:176-178.
25. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp. Diabetes Res. 2007, 10.1155/2007/61038.
26. Lowry O.H., Roserbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J.Biol. Chem. 1951, 1:265-275.
27. Manikandan R., Thiagarajan R., Beulaja S., Chindhu S., Mariammal K., Sudhandiran G., Arumugam M. Anti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: aninvitro study using isolated lens. Chem. Biol. Interact. 2009, 181:202-209.
28. Manikandan R., Thiagarajan R., Beulaja S., Sudhandiran G., Arumugam M. Curcumin prevents free radical-mediated cataractogenesis through modulations in lens calcium. Free Radic. Biol. Med. 2010, 48:483-492.
29. Marks V. An improved glucose-oxidase method for determining blood. CSF and urine glucose levels. Clin. Chim. Acta 1996, 251:19-24.
30. Middleton J.E. Experience with a glucose-oxidase method for estimating glucose in blood and CSF. Br. Med. J. 1959, 1:824-826.
31. Okafor M., Tamiya S., Delamere N.A. Sodium-calcium exchange influences the response to endothelin-1 in lens epithelium. Cell Calcium 2003, 34:231-240.
32. Onodera K., Zushida K., Kamei J. Antinociceptive effect of vitamin K2 (menatetrenone) in diabetic mice. Jpn. J. Pharmacol. 2001, 85:335-337.
33. Pfeifer M.A., Schumer M.P., Gelber D.A. Aldose reductase inhibitors: the end of an era or the need for different trial designs. Diabetes 1997, 46:82-89.
34. Plaza S.M., Lamson D.W. Vitamin K2 in bone metabolism and osteoporosis. Altern. Med. Rev. 2005, 10:24-35.
35. Rajini B.P., Shridas C., Sundari D., Muralidhar S., Chandani F., Thomas F., Sharma Y. Calcium binding properties of gamma-crystallin: calcium ion binds at the Greek key beta gamma-crystallin fold. J.Biol. Chem. 2001, 276:38464-38471.
36. Raman R., Pal S.S., Adams J.S.K., Rani K.P., Vaitheeswaran K., Sharma T. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study. Invest. Ophthalmol. Vis. Sci. 2010, 51:6253-6261.
37. Ramasamy R., Oates P.J., Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat's heart from ischemic injury. Diabetes 1997, 46:292-300.
38. Reddy P.Y., Giridharan N.V., Reddy G.B. Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats. Mol. Vis. 2012, 18:495-503.
39. Rees K., Guraewal S., Wong Y.L. Is vitamin K consumption associated with cardio-metabolic disorders: a systematic review. Maturitas 2010, 67:121-128.
40. Sakamoto N., Nishiike T., Iguchi H., Sakamoto K. Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy pro-thrombin levels. Clin. Nutr. 2003, 19:259-263.
41. Seyama Y., Kimoto S., Marukawa Y., Horiuchi M., Hayashi M., Usami E. Comparative effects of vitamin K2 and estradiol on experimental arteriosclerosis with diabetes mellitus. Int. J. Vitam. Nutr. Res. 2000, 70:301-304.
42. Shearer T.R., David L.L. Role of calcium in selenium cataract. Curr. Eye Res. 1983, 2:777-784.
43. Shearer T.R., David L.L., Anderson R.S. Selenite cataract: a review. Curr. Eye Res. 1987, 6:289-300.
44. Shirai K., Saika S., Tanaka T., Okada Y., Flanders C.K., Ooshima A., Ohnishi Y. Anew model of anterior subcapsular cataract: involvement of TGFβ/Smad signaling. Mol. Vis. 2012, 12:681-691.
45. Srivastava S.K., Ramana K.V., Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev. 2005, 26:380-382.
46. Suryanarayana P., Saraswat M., Mrudula T., Krishna P.T., Krishnaswamy K., Reddy G.B. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest. Ophthalmol. Vis. Sci. 2005, 46:2092-2099.
47. Suryanarayana P., Saraswat M., Petrash J.M., Reddy G.B. Embilica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol. Vis 2007, 13:1291-1297.
48. Tang D., Borchman D., Yappert M.C., Vrensen G.F., Rasi V. Influence of age, diabetes, and cataract on calcium, lipid-calcium, and protein-calcium relationships in human lenses. Invest. Ophthalmol. Vis. Sci. 2003, 44:2059-2066.
49. 2+ exchange. Exp. Eye Res. 1991, 52:619-627.
50. Uenishi K. Diabetes mellitus and osteoporosis. Dietary therapy of diabetes related osteoporosis. Clin. Calcium 2012, 22:1398-1402.
51. Unakar N.J., Tsui J. Sodium-potassium-dependent ATPase. II. Cytochemical localization during the reversal of galactose cataracts in rat. Invest. Ophthalmol. Vis. Sci. 1980, 19:378-385.
52. Varma S.D., Hegde K.R. Effect of α-ketoglutarate against selenite cataract formation. Exp. Eye Res. 2004, 79:913-918.
53. Sai Varsha M.K.N., Thiagarajan R., Manikandan R., Dhanasekar G. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, inhibiting NF-κB activation and iNOS expression in rat pancreas. Nutrition 2014, 10.1016/j.nut.2014.05.012.
54. Vervoot L.M.T., Ronden J.E., Thijssen H.H.W. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation. Biochem. Pharmacol. 1997, 54:871-876.
55. Vrensen G.F. Aging of the human eye lens-a morphological point of view. Comp. Biochem. Physiol. 1995, 11:519-532.
56. 2+ exchange related to cataract induced by selenite. Curr. Eye Res. 1992, 11:625-632.
57. Warren G.B., Houslay M.D., Metcalfs J.C., Birdsall N.J.M. Cholesterol is excluded from the phospholipids annulus surrounding an active calcium transport protein. Nature 1975, 255:684-687.
58. Yasuda S., Wada S. Diabetic osteopathy and vitamin K. Clin. Calcium 2006, 16:1351-1357.
59. Yoshida M., Jacques P.F., Meigs J.B. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008, 31:2092-2096.
60. Yoshida M., Booth S.L., Meigs J.B., Saltzman E., Jacques P.F. Phylloquinone intake, insulin sensitivity and glycemic status in men and women. Am. J. Clin. Nutr. 2008, 88:210-215.